Freshfields LLP has advised argenx. Wilson Sonsini Goodrich & Rosati, P.C. has advised Forte Biosciences. Argen NV ADR (NASDAQ: ARGX) and Forte Biosciences, Inc. (NASDAQ: FBRX)...
argenx Acquires Forte Biosciences for $2.2 Billion, Adding First-in-Class Anti-CD122 Antibody to Immunology Pipeline
Merck to Acquire Terns Pharmaceuticals for $6.7 Billion
Covington & Burling LLP and Gibson Dunn & Crutcher LLP have advised Merck & Co., Inc. Freshfields has advised Terns Pharmaceuticals, Inc. Merck & Co., Inc.,...
Organon’s Acquisition of Dermavant from Roivant
Freshfields advised Roivant in sale of Dermavant to Organon. Organon & Co. has announced the acquisition of Dermavant Sciences Ltd., a subsidiary of Roivant Sciences Ltd.,...
SERB Pharmaceuticals’ Acquisition of RSDL
Freshfields advised SERB Pharmaceuticals on Purchase of RSDL (Reactive Skin Decontamination Lotion) Kit from Emergent BioSolutions Inc. Mayer Brown advised SERB Pharmaceuticals and its majority shareholder,...
Roche’s $7.1bn Acquisition of Roivant from Pfizer
Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
SERB Pharmaceuticals’ Partnership with SFJ Pharmaceuticals
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
Moderna’s Ten-Year Agreement With Monash University and the State of Victoria to Produce mRNA Vaccines
Freshfields Advised Moderna on the deal. Moderna completed its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility at...
Recordati’s €750 Million Acquisition of EUSA Pharma
Freshfields, Clifford Chance and White & Case advised Recordati Industria Chimica e Farmaceutica S.p.A., while Allen & Overy advised the banks on the deal. Kirkland &...